Forget CVS, Consider This Healthcare Stock Instead

If you’ve been watching CVS Health (CVS) soar — its share price is up roughly 79% year‑to‑date in 2025 — you might think the healthcare‑stock story is already written. But according to a recent analysis, another player in the sector may offer better value right now: Centene Corporation (CNC). Centene — a large manager of U.S. government‑sponsored health plans like Medicaid, Medicare, and Affordable Care Act (ACA) coverage — is trading at a discount, yet could benefit from a possible extension of ACA subsidies under a potential two‑year proposal from Donald Trump. That extension could help millions keep their insurance, boosting Centene’s top line. Unlike CVS’s fast climb, Centene’s recent challenges have weighed on its valuation — creating what might be an attractive entry point. If ACA subsidies are extended, Centene could see a sharp rebound, making it a compelling alternative for healthcare investors looking beyond high‑flying names like CVS. #HealthcareStocks #Centene #Investing #USHealthPolicy #SlimScan #GrowthStocks #CANSLIM